{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:25:12Z","timestamp":1791181512807,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":655,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.cell.2011.09.035","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T10:45:06Z","timestamp":1319798706000},"page":"554-564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"title":["The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular Lymphoma"],"prefix":"10.1016","volume":"147","author":[{"given":"Elisa","family":"Oricchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gouri","family":"Nanjangud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew\u00a0L.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan\u00a0H.","family":"Schatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos\u00a0J.","family":"Mavrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Heguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam\u00a0B.","family":"Olshen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas\u00a0D.","family":"Socci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Teruya-Feldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Weis-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Shaknovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha\u00a0P.","family":"Himanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.S.K.","family":"Chaganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Guido","family":"Wendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2011.09.035_bib1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/CCO.0b013e32830b61ac","article-title":"Follicular non-Hodgkin lymphoma: long-term results of stem-cell transplantation","volume":"20","author":"Barr","year":"2008","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.cell.2011.09.035_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.leu.2404426","article-title":"Molecular pathways in follicular lymphoma","volume":"21","author":"Bende","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.cell.2011.09.035_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature07613","article-title":"Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival","volume":"458","author":"Bidere","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.09.035_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ccr.2010.11.024","article-title":"Constitutive canonical NF-kappaB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma","volume":"18","author":"Calado","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2011.09.035_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nature06914","article-title":"Translating insights from the cancer genome into clinical practice","volume":"452","author":"Chin","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.09.035_bib6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.09.035_bib7","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1038\/sj.onc.1210211","article-title":"Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas","volume":"26","author":"Dawson","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2011.09.035_bib8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ng1651","article-title":"Probing tumor phenotypes using stable and regulated synthetic microRNA precursors","volume":"37","author":"Dickins","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2011.09.035_bib9","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature07423","article-title":"Somatic mutations affect key pathways in lung adenocarcinoma","volume":"455","author":"Ding","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.09.035_bib10","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2003-07-2469","article-title":"VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia","volume":"103","author":"Egle","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cell.2011.09.035_bib11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature09535","article-title":"Stage-specific sensitivity to p53 restoration during lung cancer progression","volume":"468","author":"Feldser","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.09.035_bib12","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood.V80.7.1781.1781","article-title":"Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma","volume":"80","author":"Gaidano","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.cell.2011.09.035_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/geno.1998.5321","article-title":"Cloning and mapping of human chromosome 6q26-q27 deleted in B-cell non-Hodgkin lymphoma and multiple tumor types","volume":"50","author":"Hauptschein","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.cell.2011.09.035_bib14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nrc2877","article-title":"Non-germline genetically engineered mouse models for translational cancer research","volume":"10","author":"Heyer","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2011.09.035_bib15","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1073\/pnas.1004148107","article-title":"Architecture of Eph receptor clusters","volume":"107","author":"Himanen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2011.09.035_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35041577","article-title":"Regulation of repulsion versus adhesion by different splice forms of an Eph receptor","volume":"408","author":"Holmberg","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.09.035_bib17","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cell.2011.09.035_bib18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature07969","article-title":"Frequent inactivation of A20 in B-cell lymphomas","volume":"459","author":"Kato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.09.035_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri2217","article-title":"Germinal centres: role in B-cell physiology and malignancy","volume":"8","author":"Klein","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2011.09.035_bib20","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood-2009-05-222208","article-title":"Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia","volume":"115","author":"Kuang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cell.2011.09.035_bib21","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cell.2011.09.035_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ccr.2005.07.005","article-title":"A conditional feedback loop regulates Ras activity through EphA2","volume":"8","author":"Macrae","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2011.09.035_bib23","first-page":"13","article-title":"Rituximab for follicular lymphoma","volume":"2","author":"Maloney","year":"2003","journal-title":"Curr. Hematol. Rep."},{"key":"10.1016\/j.cell.2011.09.035_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ccr.2010.10.030","article-title":"BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma","volume":"18","author":"Mandelbaum","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2011.09.035_bib25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ncb2037","article-title":"Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia","volume":"12","author":"Mavrakis","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2011.09.035_bib26","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1084\/jem.20081319","article-title":"Regulation of class switch recombination and somatic mutation by AID phosphorylation","volume":"205","author":"McBride","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2011.09.035_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/418038a","article-title":"RNA interference in adult mice","volume":"418","author":"McCaffrey","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.09.035_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000108318","article-title":"Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression","volume":"118","author":"Nanjangud","year":"2007","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.cell.2011.09.035_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.09.035_bib30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/ncb1438","article-title":"The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway","volume":"8","author":"Noren","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2011.09.035_bib31","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1182\/blood-2008-08-174110","article-title":"The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas","volume":"113","author":"Novak","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cell.2011.09.035_bib32","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1182\/blood.V82.7.2157.2157","article-title":"6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma","volume":"82","author":"Offit","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.cell.2011.09.035_bib33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1242\/dmm.006296","article-title":"Mouse models of cancer as biological filters for complex genomic data","volume":"11-12","author":"Oricchio","year":"2010","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.cell.2011.09.035_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2008.03.011","article-title":"Eph-ephrin bidirectional signaling in physiology and disease","volume":"133","author":"Pasquale","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.cell.2011.09.035_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond","volume":"10","author":"Pasquale","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2011.09.035_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.20052204","article-title":"Inactivation of the PRDM1\/BLIMP1 gene in diffuse large B cell lymphoma","volume":"203","author":"Pasqualucci","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2011.09.035_bib37","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1200\/JCO.2009.26.1693","article-title":"Prognostic factors in follicular lymphoma","volume":"28","author":"Relander","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2011.09.035_bib38","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2011.09.035_bib39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nsmb.1782","article-title":"An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly","volume":"17","author":"Seiradake","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cell.2011.09.035_bib40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature07064","article-title":"IRF4 addiction in multiple myeloma","volume":"454","author":"Shaffer","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.09.035_bib41","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1074\/jbc.M309326200","article-title":"Dissecting the EphA3\/Ephrin-A5 interactions using a novel functional mutagenesis screen","volume":"279","author":"Smith","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2011.09.035_bib42","first-page":"1573","article-title":"Identification of full-length and truncated forms of Ehk-3, a novel member of the Eph receptor tyrosine kinase family","volume":"10","author":"Valenzuela","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2011.09.035_bib43","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/carcin\/bgn096","article-title":"Defining the blueprint of the cancer genome","volume":"29","author":"Velculescu","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cell.2011.09.035_bib44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05541","article-title":"Restoration of p53 function leads to tumour regression in\u00a0vivo","volume":"445","author":"Ventura","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.09.035_bib45","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1200\/JCO.2002.12.006","article-title":"Clinicopathologic correlations of genomic gains and losses in follicular lymphoma","volume":"20","author":"Viardot","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2011.09.035_bib46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature02369","article-title":"Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy","volume":"428","author":"Wendel","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.09.035_bib47","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature05529","article-title":"Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas","volume":"445","author":"Xue","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.09.035_bib48","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2008.09.061","article-title":"An oncogenomics-based in\u00a0vivo RNAi screen identifies tumor suppressors in liver cancer","volume":"135","author":"Zender","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.cell.2011.09.035_bib49","doi-asserted-by":"crossref","unstructured":"Antipenko, A., Himanen, J.P., van Leyen, K., Nardi-Dei, V., Lesniak, J., Barton, W.A., Rajashankar, K.R., Lu, M., Hoemme, C., Puschel, A.W., et\u00a0al. (2003). Structure of the semaphorin-3A receptor binding module. Neuron 39, 589\u2013598.","DOI":"10.1016\/S0896-6273(03)00502-6"},{"key":"10.1016\/j.cell.2011.09.035_bib50","doi-asserted-by":"crossref","unstructured":"Bergers, G., Javaherian, K., Lo, K.M., Folkman, J., and Hanahan, D. (1999). Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284, 808\u2013812.","DOI":"10.1126\/science.284.5415.808"},{"key":"10.1016\/j.cell.2011.09.035_bib51","doi-asserted-by":"crossref","unstructured":"Chen, K., McLellan, M.D., Ding, L., Wendl, M.C., Kasai, Y., Wilson, R.K., and Mardis, E.R. (2007). PolyScan: an automatic indel and SNP detection approach to the analysis of human resequencing data. Genome Res. 17, 659\u2013666.","DOI":"10.1101\/gr.6151507"},{"key":"10.1016\/j.cell.2011.09.035_bib52","doi-asserted-by":"crossref","unstructured":"Dickins, R.A., Hemann, M.T., Zilfou, J.T., Simpson, D.R., Ibarra, I., Hannon, G.J., and Lowe, S.W. (2005). Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat. Genet. 37, 1289\u20131295.","DOI":"10.1038\/ng1651"},{"key":"10.1016\/j.cell.2011.09.035_bib53","doi-asserted-by":"crossref","unstructured":"Egle, A., Harris, A.W., Bath, M.L., O'Reilly, L., and Cory, S. (2004). VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood 103, 2276\u20132283.","DOI":"10.1182\/blood-2003-07-2469"},{"key":"10.1016\/j.cell.2011.09.035_bib54","doi-asserted-by":"crossref","unstructured":"Gordon, D., Abajian, C., and Green, P. (1998). Consed: a graphical tool for sequence finishing. Genome Res. 8, 195\u2013202.","DOI":"10.1101\/gr.8.3.195"},{"key":"10.1016\/j.cell.2011.09.035_bib55","doi-asserted-by":"crossref","unstructured":"Himanen, J.P., Henkemeyer, M., and Nikolov, D.B. (1998). Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2. Nature 396, 486\u2013491.","DOI":"10.1038\/24904"},{"key":"10.1016\/j.cell.2011.09.035_bib56","doi-asserted-by":"crossref","unstructured":"Mandelbaum, J., Bhagat, G., Tang, H., Mo, T., Brahmachary, M., Shen, Q., Chadburn, A., Rajewsky, K., Tarakhovsky, A., Pasqualucci, L., et\u00a0al. (2010). BLIMP1 Is a Tumor Suppressor Gene Frequently Disrupted in Activated B Cell-like Diffuse Large B Cell Lymphoma. Cancer Cell 18, 568\u2013579.","DOI":"10.1016\/j.ccr.2010.10.030"},{"key":"10.1016\/j.cell.2011.09.035_bib57","doi-asserted-by":"crossref","unstructured":"Mavrakis, K.J., Wolfe, A.L., Oricchio, E., Palomero, T., de Keersmaecker, K., McJunkin, K., Zuber, J., James, T., Khan, A.A., Leslie, C.S., et\u00a0al. (2010). Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T\u00a0cell acute lymphoblastic leukemia. Nat. Cell Biol. 12, 372\u2013379.","DOI":"10.1038\/ncb2037"},{"key":"10.1016\/j.cell.2011.09.035_bib58","doi-asserted-by":"crossref","unstructured":"Mavrakis, K.J., Zhu, H., Silva, R.L., Mills, J.R., Teruya-Feldstein, J., Lowe, S.W., Tam, W., Pelletier, J., and Wendel, H.G. (2008). Tumorigenic activity and therapeutic inhibition of Rheb GTPase. Genes Dev. 22, 2178\u20132188.","DOI":"10.1101\/gad.1690808"},{"key":"10.1016\/j.cell.2011.09.035_bib59","doi-asserted-by":"crossref","unstructured":"McBride, K.M., Gazumyan, A., Woo, E.M., Schwickert, T.A., Chait, B.T., and Nussenzweig, M.C. (2008). Regulation of class switch recombination and somatic mutation by AID phosphorylation. J. Exp. Med. 205, 2585\u20132594.","DOI":"10.1084\/jem.20081319"},{"key":"10.1016\/j.cell.2011.09.035_bib60","doi-asserted-by":"crossref","unstructured":"Nickerson, D.A., Tobe, V.O., and Taylor, S.L. (1997). PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 25, 2745\u20132751.","DOI":"10.1093\/nar\/25.14.2745"},{"key":"10.1016\/j.cell.2011.09.035_bib61","doi-asserted-by":"crossref","unstructured":"Scott, C.L., Gil, J., Hernando, E., Teruya-Feldstein, J., Narita, M., Martinez, D., Visakorpi, T., Mu, D., Cordon-Cardo, C., Peters, G., et\u00a0al. (2007). Role of the chromobox protein CBX7 in lymphomagenesis. Proc. Natl. Acad. Sci. USA 104, 5389\u20135394.","DOI":"10.1073\/pnas.0608721104"},{"key":"10.1016\/j.cell.2011.09.035_bib62","doi-asserted-by":"crossref","unstructured":"Shaknovich, R., Figueroa, M.E., and Melnick, A. (2010). HELP (HpaII tiny fragment enrichment by ligation-mediated PCR) assay for DNA methylation profiling of primary normal and malignant B lymphocytes. Methods Mol. Biol. 632, 191\u2013201.","DOI":"10.1007\/978-1-60761-663-4_12"},{"key":"10.1016\/j.cell.2011.09.035_bib63","doi-asserted-by":"crossref","unstructured":"Thompson, R.F., Reimers, M., Khulan, B., Gissot, M., Richmond, T.A., Chen, Q., Zheng, X., Kim, K., and Greally, J.M. (2008). An analytical pipeline for genomic representations used for cytosine methylation studies. Bioinformatics 24, 1161\u20131167.","DOI":"10.1093\/bioinformatics\/btn096"},{"key":"10.1016\/j.cell.2011.09.035_bib64","doi-asserted-by":"crossref","unstructured":"Veeriah, S., Taylor, B.S., Meng, S., Fang, F., Yilmaz, E., Vivanco, I., Janakiraman, M., Schultz, N., Hanrahan, A.J., Pao, W., et\u00a0al. (2010). Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat. Genet. 42, 77\u201382.","DOI":"10.1038\/ng.491"},{"key":"10.1016\/j.cell.2011.09.035_bib65","doi-asserted-by":"crossref","unstructured":"Wendel, H.G., de Stanchina, E., Cepero, E., Ray, S., Emig, M., Fridman, J.S., Veach, D.R., Bornmann, W.G., Clarkson, B., McCombie, W.R., et\u00a0al. (2006). Loss of p53 impedes the antileukemic response to BCR-ABL inhibition. Proc. Natl. Acad. Sci. USA 103, 7444\u20137449.","DOI":"10.1073\/pnas.0602402103"},{"key":"10.1016\/j.cell.2011.09.035_bib66","doi-asserted-by":"crossref","unstructured":"Wendel, H.G., De Stanchina, E., Fridman, J.S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., and Lowe, S.W. (2004). Survival signaling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428, 332\u2013337.","DOI":"10.1038\/nature02369"},{"key":"10.1016\/j.cell.2011.09.035_bib67","doi-asserted-by":"crossref","unstructured":"Xu, K., Rajashankar, K.R., Chan, Y.P., Himanen, J.P., Broder, C.C., and Nikolov, D.B. (2008). Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc. Natl. Acad. Sci. USA 105, 9953\u20139958.","DOI":"10.1073\/pnas.0804797105"},{"key":"10.1016\/j.cell.2011.09.035_bib68","doi-asserted-by":"crossref","unstructured":"Yu, D., and Thomas-Tikhonenko, A. (2002). A non-transgenic mouse model for B cell lymphoma: in\u00a0vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis. Oncogene 21, 1922\u20131927.","DOI":"10.1038\/sj.onc.1205244"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867411011469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867411011469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:15:17Z","timestamp":1758798917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867411011469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0092867411011469"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2011.09.035","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2011.09.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}